Evidence map›Paper›PMID 32651756›Full record

ArticleMolecular neurobiology2020

Ouabain Modulates the Functional Interaction Between Na,K-ATPase and NMDA Receptor.

Evgeny E Akkuratov, Linda Westin, Erika Vazquez-Juarez, Minttu de Marothy, Aleksandra K Melnikova, Hans Blom, Maria Lindskog, Hjalmar Brismar, Anita Aperia

Open access · hybridAbstract read
In one paragraph

Article in Molecular neurobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. NaBiomedicines · 2023
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Evgeny E AkkuratovScience for Life Laboratory, Department of Applied Physics, Kungliga Tekniska Högskolan, Stockholm, Sweden.
Linda WestinScience for Life Laboratory, Department of Women's and Children's health, Karolinska Institutet, Stockholm, Sweden.
Erika Vazquez-JuarezDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Minttu de MarothyScience for Life Laboratory, Department of Women's and Children's health, Karolinska Institutet, Stockholm, Sweden.
Aleksandra K MelnikovaFaculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia, 119234.
Hans BlomScience for Life Laboratory, Department of Applied Physics, Kungliga Tekniska Högskolan, Stockholm, Sweden.
Maria LindskogDepartment of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Hjalmar BrismarScience for Life Laboratory, Department of Applied Physics, Kungliga Tekniska Högskolan, Stockholm, Sweden. brismar@kth.se.ORCID http://orcid.org/0000-0003-0578-4003
Anita AperiaScience for Life Laboratory, Department of Women's and Children's health, Karolinska Institutet, Stockholm, Sweden.
Science for Life Laboratory · SEKarolinska Institutet · SELomonosov Moscow State University · RU

Funding

Brain and Behavior Research Foundation 245719Karolinska Institutet KID2012Vetenskapsrådet 2015-04198Vetenskapsrådet 521-2013-3905Vetenskapsrådet 521-2014-388299
6 · The paper itself

Abstract

The N-methyl-D-aspartate (NMDA) receptor plays an essential role in glutamatergic transmission and synaptic plasticity and researchers are seeking for different modulators of NMDA receptor function. One possible mechanism for its regulation could be through adjacent membrane proteins. NMDA receptors coprecipitate with Na,K-ATPase, indicating a potential interaction of these two proteins. Ouabain, a mammalian cardiotonic steroid that specifically binds to Na,K-ATPase and affects its conformation, can protect from some toxic effects of NMDA receptor activation. Here we have examined whether NMDA receptor activity and downstream effects can be modulated by physiological ouabain concentrations. The spatial colocalization between NMDA receptors and the Na,K-ATPase catalytic subunits on dendrites of cultured rat hippocampal neurons was analyzed with super-resolution dSTORM microscopy. The functional interaction was analyzed with calcium imaging of single hippocampal neurons exposed to 10 μM NMDA in presence and absence of ouabain and by determination of the ouabain effect on NMDA receptor-dependent long-term potentiation. We show that NMDA receptors and the Na,K-ATPase catalytic subunits alpha1 and alpha3 exist in same protein complex and that ouabain in nanomolar concentration consistently reduces the calcium response to NMDA. Downregulation of the NMDA response is not associated with internalization of the receptor or with alterations in its state of Src phosphorylation. Ouabain in nanomolar concentration elicits a long-term potentiation response. Our findings suggest that ouabain binding to a fraction of Na,K-ATPase molecules that cluster with the NMDA receptors will, via a conformational effect on the NMDA receptors, cause moderate but consistent reduction of NMDA receptor response at synaptic activation.

Indexed as

AnimalsCalciumDown-RegulationHippocampusModels, BiologicalNeuronsN-MethylaspartateOuabainPhosphorylationPhosphotyrosineProtein BindingRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateSodium-Potassium-Exchanging ATPasesrc-Family KinasesSynapsesCalciumN-MethylaspartateOuabainPhosphotyrosineReceptors, N-Methyl-D-AspartateSodium-Potassium-Exchanging ATPasesrc-Family KinasesCalciumLTPNa,K-ATPaseNMDAROuabainProtein-protein interactionSuper-resolution microscopy

Identifiers

PMID32651756
PMCPMC7467916
OpenAlexW3041944682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.